The Department of Justice has opened an antitrust inquiry into Andreessen Horowitz, questioning whether the venture firm's partners can lawfully hold board seats at multiple artificial intelligence companies that compete directly with one another. According to The Decoder, the review focuses on a16z's pattern of placing its own general partners on the boards of AI startups that go after the same customers, engineers, and compute capacity.

The firm has not been accused of wrongdoing, and a DOJ inquiry does not guarantee formal action will follow. But the fact that regulators are looking at board composition, rather than funding terms or acquisition behavior, signals a new front in how antitrust law is being applied to the AI boom — one that targets governance structure instead of deal size.

The legal hook is a 1914 law nobody enforced for decades

The relevant statute is Section 8 of the Clayton Antitrust Act, which bars one person from serving as a director of two competing corporations once those companies clear certain revenue and market-overlap thresholds. The logic is simple: a director sitting on both sides of a competitive relationship has the access and the incentive to soften that competition, whether through shared strategy, coordinated hiring, or steering deals between portfolio companies rather than letting them fight each other for the same resources.

For most of the last several decades, Section 8 sat largely unused. Antitrust agencies have only recently started applying it more aggressively to venture capital and private equity, where a single fund can hold board seats across a dozen or more companies in the same sector — a structure that is far more common in tech investing than in traditional industries.

Why AI makes this hard to avoid

Generative AI funding is unusually concentrated. A short list of large, generalist funds — a16z among the most active — writes the biggest checks across foundation model labs, coding assistants, AI agents, and infrastructure startups that increasingly overlap in what they build and sell. Taking a board seat is typically the price of leading a round, since it's how a fund monitors its investment and shapes strategy. Avoiding overlap entirely would mean either skipping some of the sector's best deals or giving up the governance influence that justifies writing a large check in the first place.

That tension is precisely what puts a16z's board strategy under scrutiny now: a firm built around deep, hands-on involvement with portfolio companies is structurally more exposed to interlocking-directorate risk than a fund that writes passive checks and stays off the board.

What it means for founders and other VCs

None of this is guaranteed to happen — the DOJ inquiry is still an inquiry, not a ruling. But it puts every large AI-focused fund on notice that governance structure, not just capital, is now a compliance question.

AiiN's takeaway

For builders, the practical signal isn't about a16z specifically — it's about how a term sheet gets negotiated going forward. Founders should expect more questions from counsel about who else a prospective board member sits with, and investors should expect more paperwork around information barriers between competing portfolio companies. In our estimation, this probe is likely to push at least some large funds toward observer seats or single-purpose board designees in crowded AI categories, even before any formal DOJ finding is reached, simply to reduce legal exposure while a case like this is pending.